Share
This week's digest includes our Built With Biology Q2 2021 Investment Report

View in Browser »

Hi ,


In this week’s Digest, we are proud to deliver an insightful report from industry analyst Mark Bünger on the record-breaking $4.2B in venture funding secured by SynBio start-ups in Q2, 2021. All indicators point to the fact that 2021 investment should exceed the sum total of the previous 11 years combined (since we began measuring in 2009). 


You may also notice that we’re working to revise our Digest format. Our goals over the coming weeks are to enhance readability, provide for more visual interactivity, and generate insightful, original commentary.


We hope you enjoy reading… and as always, appreciate hearing from you!


Larry


Larry Upton

Editor in Chief

larry.upton@synbiobeta.com


Q2 2021 INVESTMENT REPORT

The second quarter of 2021 was another record-breaking period for the synthetic biology startup community. Building on the extremely high amount of investment we saw in Q1 ($4.7 billion), Q2 also brought in more than $4.2 billion in venture funding to synthetic biology startups.  

The amount of money raised by synthetic biology startups in the second quarter proved that the remarkable performance in Q1 wasn't a one-time fluke. On the contrary, the money was spread widely over nearly every dimension, from synbio stack to stage of investment, company size, application, and geography. 

For further information, please see the complete report from industry-leading analyst Mark Bünger here.

Learn More »

Alternative-milk company Perfect Day raises $350 million, prepares for IPO

Food-tech startup advised by Leonardo DiCaprio is valued at roughly $1.5 billion.

Keep Reading »

How these founders are detoxifying the denim industry -- and saving the planet.

Tammy Hsu and Michelle Zhu are on a mission to revolutionize the industry with planet-friendly, microbe-based dyes.

Keep Reading »

On a journey to drastically speed up cell therapy manufacturing, Kytopen lands $30M Series A

The funding will go toward commercializing it's system for accelerating engineered cell therapy production, known as Flowfect Tx.

Keep Reading »

This dazzling new branding is a lesson in combatting scientific misinformation

A first look at biodesign firm Geltor's stunning new brand identity, designed by &Walsh.

Keep Reading »

Aquafeed Investors Webinar: Funding the Future of Food

The F3 - Future of Fish Feed will convene a panel of aquaculture investors to discuss areas of interest, investing approaches, and favorite up-and-coming alternative ingredients.

Keep Reading »

Chemicals & Materials Digital Conference

November 17th, 2021

$49.99 for digital conference only.
FREE to all SynBioBeta live conference ticket holders.

Register Now »


Registration is now open for the SynBioBeta Chemicals & Materials online event on November 17th! Meet the innovators making bioplastics from captured CO2, aviation fuel from microbes, leather from mushrooms, and bricks from bacteria.

If you already have your SynBioBeta live conference ticket for January 25-27, you will be added to the event automatically, so no need to register. You will receive an email on October 27th with login information so you can explore the sessions and connect with other attendees.

MORE TO EXPLORE

DNA-Based Data Storage Platform Catalog Raises $35M

Keep Reading »

In Vivo Gene Editing Grabs The Spotlight After Triumph, But Challenges Loom

Keep Reading »

Latch Bio Emerges From Stealth With Seed Funding Round Led by Lux Capital

Keep Reading »

Here's All 10 Companies From IndieBio's Latest New York Cohort

Keep Reading »

A Gene-Editing Experiment Let These Patients With Vision Loss See Color Again

Keep Reading »

The NSF Released A New Solicitation Topic, Engineering Living Systems Which Will Support Research To Advance The Design, Modeling, Fabrication, and Manufacturing of Engineered Living Systems

Keep Reading »

NFX Closes On Pre-Seed And Seed Fund 3 At $450M

Keep Reading »

Novo Nordisk Foundation Pumps €85M Into Carbon Capture Research

Keep Reading »

Vision Of Expanded Genetic Code For Making Novel Biologics Comes Closer To Realization

Keep Reading »

Webinar: Newton's Cradle, Exploring Rational And Empirical Design Space With Engineering Biology

Keep Reading »

Amyris Partners With Inscripta To Enhance Development of Susstainable Ingredients Using The Onyx™ Genome Engineering Platform

Keep Reading »

Cyanobacteria Engineered To Accept External Electricity Turn Carbon Dioxide Into Fuel

Keep Reading »

Delta Air To Buy Systainable Aviation Fuel From Aemetis In Over $1 Bln Deal

Keep Reading »

Clara Foods Rebrands As The EVERY Company, Launches 'Nearly Invisible' Animal-Free Egg Protein (Without Chickens)

Keep Reading »

New Rules Will Make UK Gene-Edited Crop Research Easier

Keep Reading »

We've Got More »

WHO'S HIRING

Access The Job Board »

SynBioBeta, LLC
3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com

If you no longer wish to receive our emails, you can unsubscribe here.
Modify Your Email Preferences


Email Marketing by ActiveCampaign